Five medical schools face new federal civil rights admissions probes

The U.S. Department of Education said July 22 that its Office for Civil Rights has opened Title VI admissions investigations into five medical schools: Dartmouth College’s Geisel School of Medicine, East Carolina University’s Brody School of Medicine, St. Louis University School of Medicine, Western University of Health Sciences, and William Carey University College of Osteopathic Medicine. The department said the cases are part of a joint effort with the U.S. Department of Health and Human Services’ Office for Civil Rights and the Justice Department’s Civil Rights Division. Crucially, these are investigations, not findings that the schools violated the law. (ed.gov)

What changed is not just the administration’s rhetoric, but the level of specificity. Federal officials have moved from broad warnings about medical-school admissions to naming institutions in active cases, at a moment when the 2027 AMCAS application is already open and schools are working through the 2026-27 admissions cycle for students hoping to start medical school in fall 2027. OCR says Title VI bars discrimination based on race, color, or national origin at institutions that receive federal funds, and its public pending-cases page says inclusion on that list means an investigation has begun, not that OCR has reached a decision. (ed.gov)

In early public responses, East Carolina officials told Public Radio East that Brody is in full compliance with the law and will cooperate with the investigation. St. Louis Public Radio reported that Saint Louis University did not immediately respond to a request for comment, and New Hampshire Public Radio reported that Dartmouth officials had not yet responded to requests for comment on July 22. (publicradioeast.org)

From unnamed reviews to named schools

The July 22 announcement extends a broader medical-school enforcement campaign that higher-ed leaders can no longer treat as hypothetical. On June 4, the Justice Department said it had opened 15 additional investigations into potential race discrimination in medical-school admissions, after announcing findings earlier in May that Yale School of Medicine and UCLA’s David Geffen School of Medicine had discriminated on the basis of race. DOJ followed with a June 10 finding against UC Davis and a July 20 finding against UC San Diego. In each case, the department said it was enforcing Title VI as interpreted by the Supreme Court’s 2023 decision in Students for Fair Admissions v. Harvard. (justice.gov)

That matters because the government is signaling what kinds of evidence it believes will show unlawful conduct. In the recent California findings, DOJ said investigators examined not only official admissions policies, but also internal workflow: whether committees used extra screening layers, whether reviewers could see applicants’ race during key stages, and whether schools used facially race-neutral factors such as hardship or socioeconomic disadvantage as proxies for race. Yale, Davis, and UC San Diego all were accused by DOJ of using proxies or internal processes that, in the department’s view, kept race in the system after Students for Fair Admissions. (justice.gov)

The compliance issue now facing admissions offices

For medical schools and the universities that oversee them, the likely takeaway is operational, not just legal. If federal investigators are scrutinizing file-review stages, secondary-application questions, interviewer guidance, and the way disadvantage metrics are translated into admissions scores, then campuses will need auditable records showing how those tools are designed and used. Institutions that say they pursue socioeconomic mobility, rural service, or primary-care pipelines through race-neutral means may now need to prove, with documentation and reviewer training materials, that those criteria are tied to mission rather than serving as substitutes for race. That is analysis, but it is analysis grounded in the kinds of practices DOJ says it reviewed in its recent medical-school findings. (justice.gov)

The pressure is especially acute because some of the schools now under investigation have highly specific workforce missions. Brody says its mission is to increase the supply of primary care physicians for North Carolina and that nearly all of its students are state residents. William Carey says its osteopathic college gives strong preference to applicants from Mississippi, the Gulf South, and rural or medically underserved areas, and describes its mission as preparing physicians with an emphasis on primary care. Geisel says its vision includes building a diverse and inclusive community, while Saint Louis University says its medical school mission includes community engagement and social justice. None of those goals is itself evidence of illegal discrimination. But in the current enforcement environment, mission-driven admissions language that once read as routine may now invite regulators to ask exactly how those goals are translated into scoring rubrics, interview prompts, and final committee decisions. (medicine.ecu.edu)

That is the second-order effect campuses should pay attention to. Institutions may respond to the headline risk by scrubbing public-facing language about diversity or underserved communities. But the more durable challenge is internal: preserving lawful ways to recruit future physicians for rural regions, safety-net systems, and primary-care shortages without creating review practices that federal investigators will characterize as racial balancing or proxy discrimination. The schools caught in this round of probes include public and private institutions and schools with very different stated missions, which suggests the administration is testing a broad theory of compliance rather than targeting only one kind of campus. (ed.gov)

What happens next, and what to watch

OCR’s public materials say investigations begin only after the agency determines it can investigate a legally sufficient complaint or matter, and its pending-cases page says listed institutions are under investigation but not yet found in violation. OCR also publishes resolution documents and states in its case-processing materials that some matters can be resolved through voluntary agreements before findings are issued. In other words, these cases could end in dismissal, negotiated changes, or formal findings, and outside campuses will be watching closely because the resolution documents may become the clearest playbook yet for what federal officials think a compliant admissions process looks like after Students for Fair Admissions. (ed.gov)

For now, the immediate lesson for medical-school leaders is narrower and more practical: do not assume that a race-neutral policy statement is enough. The government’s recent medical-school cases show an interest in how admissions actually operates, down to subgroups, scoring systems, and reviewer access to demographic information. With the new AMCAS cycle already underway, the next development worth watching is whether these five investigations quickly produce document requests, public listings on OCR’s pending-cases database, or early resolution agreements that force changes before another class is fully assembled. (students-residents.aamc.org)